Straka Marek, Dubinová Martina, Liptáková Adriána
Medical Faculty, Institute of Microbiology, Comenius University in Bratislava, 81108 Bratislava, Slovakia.
Department of Microbiology and Virology, Faculty of Natural Sciences, Comenius University in Bratislava, Ilkovičova 6, 84104 Bratislava, Slovakia.
Microorganisms. 2022 Jul 6;10(7):1365. doi: 10.3390/microorganisms10071365.
Treatment of infections caused by bacteria has become more complex due to the increasing number of bacterial strains that are resistant to conventional antimicrobial therapy. A highly promising alternative appears to be bacteriophage (phage) therapy, in which natural predators of bacteria, bacteriophages, play a role. Although these viruses were first discovered in 1917, the development of phage therapy was impacted by the discovery of antibiotics, which spread more quickly and effectively in medical practice. Despite this, phage therapy has a long history in Eastern Europe; however, Western countries are currently striving to reintroduce phage therapy as a tool in the fight against diseases caused by drug-resistant bacteria. This review describes phage biology, bacterial and phage competition mechanisms, and the benefits and drawbacks of phage therapy. The results of various laboratory experiments, and clinical cases where phage therapy was administered, are described.
由于对传统抗菌疗法耐药的细菌菌株数量不断增加,细菌感染的治疗变得更加复杂。一种极具前景的替代方法似乎是噬菌体疗法,即细菌的天然捕食者——噬菌体发挥作用的疗法。尽管这些病毒于1917年首次被发现,但噬菌体疗法的发展受到了抗生素发现的影响,抗生素在医学实践中传播得更快、更有效。尽管如此,噬菌体疗法在东欧有着悠久的历史;然而,西方国家目前正努力重新引入噬菌体疗法,将其作为对抗耐药菌引起疾病的一种工具。这篇综述描述了噬菌体生物学、细菌与噬菌体的竞争机制以及噬菌体疗法的优缺点。还描述了各种实验室实验的结果以及应用噬菌体疗法的临床病例。